Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewan H Forrest

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Liver|September 26, 2002
Improvement in cholestasis associated with total parenteral nutrition after treatment with an antibody against tumour necrosis factor alphaEwan H Forrest, K A Oien, S Dickson, et al.
Digestive Diseases and Sciences|November 14, 2022
Hepatocellular Carcinoma Risk Scores Predict Patients Under Surveillance at Low Risk of Benefit and High Risk of HarmChris Curran, Matthew Priest, Shouren Datta, et al.
Frontline Gastroenterology|August 26, 2017
Improvement of parenteral nutrition-associated cholestasis in an adult using fish oil-based parenteral nutritionLisa H Moyes, Rizwana Hamid, Juliet Clutton, et al.
Journal of Hepatology|March 11, 2018
Reply to: "The long-term prognosis of alcoholic hepatitis is poor and independent of disease severity for patients surviving an acute episode"Ewan H Forrest, Stephen R Atkinson, Paul Richardson, et al.
Journal of Hepatology|November 28, 2017
Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitisEwan H Forrest, Stephen R Atkinson, Paul Richardson, et al.
Journal of Hepatology|August 29, 2018
Prevalent acute-on-chronic liver failure and response to corticosteroids in alcoholic hepatitisEwan H Forrest, Stephen R Atkinson, Paul Richardson, et al.
Journal of Clinical Pathology|May 27, 2021
Audit of medical (non-targeted) liver biopsy specimen quality, pathology reporting and effect on patient managementSidhant Seth, Ewan H Forrest, Judith M Morris, et al.
The American Journal of Gastroenterology|June 12, 2018
ACG Clinical Guideline for Alcoholic Liver Disease: The MELD Threshold for Corticosteroid Treatment has Yet to be EstablishedEwan H Forrest, Stephen R Atkinson, Paul Richardson, et al.
Alimentary Pharmacology & Therapeutics|December 9, 2020
Carvedilol is associated with improved survival in patients with cirrhosis: a long-term follow-up studyHannah R McDowell, Cher Shiong Chuah, Dhiraj Tripathi, et al.
European Journal of Gastroenterology & Hepatology|January 16, 2010
Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case seriesJude M Morris, Karin A Oien, Marie McMahon, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Liver|September 26, 2002
Improvement in cholestasis associated with total parenteral nutrition after treatment with an antibody against tumour necrosis factor alphaEwan H Forrest, K A Oien, S Dickson, et al.
Digestive Diseases and Sciences|November 14, 2022
Hepatocellular Carcinoma Risk Scores Predict Patients Under Surveillance at Low Risk of Benefit and High Risk of HarmChris Curran, Matthew Priest, Shouren Datta, et al.
Frontline Gastroenterology|August 26, 2017
Improvement of parenteral nutrition-associated cholestasis in an adult using fish oil-based parenteral nutritionLisa H Moyes, Rizwana Hamid, Juliet Clutton, et al.
Journal of Hepatology|March 11, 2018
Reply to: "The long-term prognosis of alcoholic hepatitis is poor and independent of disease severity for patients surviving an acute episode"Ewan H Forrest, Stephen R Atkinson, Paul Richardson, et al.
Journal of Hepatology|November 28, 2017
Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitisEwan H Forrest, Stephen R Atkinson, Paul Richardson, et al.
Journal of Hepatology|August 29, 2018
Prevalent acute-on-chronic liver failure and response to corticosteroids in alcoholic hepatitisEwan H Forrest, Stephen R Atkinson, Paul Richardson, et al.
Journal of Clinical Pathology|May 27, 2021
Audit of medical (non-targeted) liver biopsy specimen quality, pathology reporting and effect on patient managementSidhant Seth, Ewan H Forrest, Judith M Morris, et al.
The American Journal of Gastroenterology|June 12, 2018
ACG Clinical Guideline for Alcoholic Liver Disease: The MELD Threshold for Corticosteroid Treatment has Yet to be EstablishedEwan H Forrest, Stephen R Atkinson, Paul Richardson, et al.
Alimentary Pharmacology & Therapeutics|December 9, 2020
Carvedilol is associated with improved survival in patients with cirrhosis: a long-term follow-up studyHannah R McDowell, Cher Shiong Chuah, Dhiraj Tripathi, et al.
European Journal of Gastroenterology & Hepatology|January 16, 2010
Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case seriesJude M Morris, Karin A Oien, Marie McMahon, et al.
Pageof 4